120 filings
Page 2 of 6
8-K
6s1d82b09vi5qvuee
2 Jun 22
Departure of Directors or Certain Officers
4:03pm
8-K
gja4k mjzc29u5v7s
10 May 22
Xenon Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
4:16pm
8-K
we7skwp wh
22 Mar 22
Unregistered Sales of Equity Securities
4:04pm
8-K
0bck5xbddzntpw647om
10 Mar 22
Results of Operations and Financial Condition
4:09pm
8-K
gl1vok wy
1 Mar 22
Entry into a Material Definitive Agreement
4:41pm
8-K
u02kwe7ld
1 Mar 22
Xenon Pharmaceuticals Reports 2021 Financial Results and Provides Corporate Update
12:00am
8-K
5rwh9aauzu yv3u2sm
12 Jan 22
Xenon Pharmaceuticals Announces Collaboration with Neurocrine Biosciences Achieves $15.0 Million Regulatory Milestone
8:04am
8-K
5eiin
1 Dec 21
Entry into a Material Definitive Agreement
4:02pm
8-K
q8278vbs20qvfk
10 Nov 21
Xenon Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Update
4:14pm
8-K
a4j1 lyyym
6 Oct 21
Other Events
4:50pm
8-K
0jryelukl9y2 kjau3
4 Oct 21
Xenon Pharmaceuticals Announces Positive Topline Results from Phase 2b ‘X-TOLE’ Clinical Trial of XEN1101 for the Treatment of Focal Epilepsy
7:03am
8-K
defh26xrg z8jly
8 Sep 21
Xenon Pharmaceuticals Announces Collaboration with Neurocrine Biosciences Achieves $10.0 Million Regulatory Milestone
8:32am
8-K
8m4axj2ywodco yb
23 Aug 21
Xenon Pharmaceuticals Strengthens Leadership Team with Appointment of Dr. Christopher Kenney as Chief Medical Officer
8:33am
8-K
gklq0phbil xd7rc
11 Aug 21
Xenon Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Update
4:16pm
8-K
w6ln8pag30x
3 Jun 21
Submission of Matters to a Vote of Security Holders
5:25pm
8-K
euor px6227
11 May 21
Xenon Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update
4:17pm
8-K
3wty3cgwlpfz8 vw
12 Mar 21
Departure of Directors or Certain Officers
5:03pm
8-K
a6uwqdq 9cd2lrsij15
10 Mar 21
Other Events
5:24pm
8-K
48kuwxjy8invrcj zbvf
1 Mar 21
Xenon Pharmaceuticals Reports 2020 Financial Results and Provides Corporate Update
4:04pm
8-K/A
rk1spnz vs0nyt795pa0
14 Jan 21
Departure of Directors or Certain Officers
8:09am